EP3519419

BETA-LAKTAMSE HEMLAR

  • Status:
    EP Einkaleyfi fallið úr gildi
  • EP appl. date:
    28.9.2017
  • EP published:
    27.5.2020
  • EP application number:
    17791737.4
  • Max expiry date:
    27.9.2037
  • Expiry date:
    27.9.2022
  • Title:
    BETA-LACTAMASE INHIBITORS

Timeline

Today
28.9.2017EP application
27.5.2020EP Publication
22.6.2020Translation submitted
15.8.2020Registration published
27.9.2022Expires

Owner

  • Name:
    Novartis AG
  • Address:
    Lichtstrasse 35, 4056 Basel, CH

Inventor

  • Name:
    CASAREZ, Anthony
  • Address:
    Emeryville, California 94608, US
  • Name:
    FUREGATI, Markus
  • Address:
    4002 Basel, CH
  • Name:
    KOCH, Guido
  • Address:
    4002 Basel, CH
  • Name:
    LIN, Xiaodong
  • Address:
    Emeryville, California 94608, US
  • Name:
    OSSOLA, Flavio
  • Address:
    4002 Basel, CH
  • Name:
    RECK, Folkert
  • Address:
    Emeryville, California 94608, US
  • Name:
    SIMMONS, Robert Lowell
  • Address:
    Emeryville, California 94608, US
  • Name:
    ZHU, Qingming
  • Address:
    Emeryville, California 94608, US

Agent

  • Name:
    G.H. Sigurgeirsson ehf.
  • Address:
    Borgartúni 26, 105, Reykjavík,

Priority

  • Number:
    201662401022 P
  • Date:
    28.9.2016
  • Country:
    US

Classification

  • Categories:
    C07D 471/18, A61K 31/496, A61K 45/06, A61K 31/5025, A61K 31/551, A61K 31/546, A61K 31/407, A61P 31/04, A61K 31/427, A61K 31/431, A61K 31/4545

Annual fees

Number

Paid

Expires

Payer

Number: 4

Paid: 18.9.2020

Expires: 27.9.2021

Payer: G.H. Sigurgeirsson ehf.

Number: 5

Paid: 10.9.2021

Expires: 27.9.2022

Payer: G.H. Sigurgeirsson ehf.

Upload documents